Randy Dotinga

News

‘Modest’ benefit for lecanemab in Alzheimer’s disease, but adverse events are common

Author:: Randy Dotinga

Publish date: November 30, 2022

The Food and Drug Administration is expected to make a decision about possible approval of the drug in January 2023.

News

Atezolizumab fails to improve outcomes in postsurgery kidney cancer

Author:: Randy Dotinga

Publish date: November 11, 2022

Study authors call for greater attention to patient selection for RCC adjuvant immunotherapy.

News

Chronic hepatitis B infections associated with a range of liver malignancies

Author:: Randy Dotinga

Publish date: November 9, 2022

Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.

News

Previous breast cancer doesn’t increase poor outcomes in pregnancy, study finds

Author:: Randy Dotinga

Publish date: November 9, 2022

Mothers with cancer diagnoses were more likely to undergo cesarean section, however.

Article

Pain in Cancer Survivors: Assess, Monitor, and Ask for Help

Author:: Randy Dotinga

Publish date: November 1, 2022

News

Hormone therapy–depression link may depend on mode of administration

Author:: Randy Dotinga

Publish date: November 1, 2022

Registry study suggests different effects from local and systemic types of hormone therapy plus age.

News

Post Roe, pregnant SCD patients facing “dire” risks

Author:: Randy Dotinga

Publish date: October 31, 2022

Doctors warn that lost abortion rights put many pregnant patients with sickle cell disease (SCD) in danger.

News

Fertility physicians say they lack access to miscarriage drugs

Author:: Randy Dotinga

Publish date: October 27, 2022

Even before Dobbs, few offered mifepristone/misoprostol to patients with early pregnancy loss, small survey suggests.

News

HPV-positive women who undergo IVF don’t have worse outcomes

Author:: Randy Dotinga

Publish date: October 27, 2022

They were more likely than counterparts to get pregnant and have live births, new study finds.

Article

Tips on Better Patients Communication

Author:: Randy Dotinga

Publish date: October 26, 2022

News

Gloom lifting as MCL treatments evolve

Author:: Randy Dotinga

Publish date: October 21, 2022

A rare blood cancer remains incurable, yet new therapies have yielded improved prognoses and survival rates.

Article

In VA Oncology, Discussion Groups Are Transforming the Workplace

Author:: Randy Dotinga

Publish date: October 19, 2022

Article

Burnout Is Rampant, But Oncologists Can Turn the Tide

Author:: Randy Dotinga

Publish date: October 10, 2022

News

Worldwide trial seeks to revolutionize pediatric leukemia care

Author:: Randy Dotinga

Publish date: October 3, 2022

Leukemia & Lymphoma Society project offers free genomic screening, plus access to subtrials.

News

Drug combo holds promise of better AML outcomes

Author:: Randy Dotinga

Publish date: September 30, 2022

Study suggests that the venetoclax-gilteritinib drug combination “potentially improves response frequency and depth.”